The FGFR inhibitor pemigatinib overcomes cancer drug resistance to KRAS G12C inhibitors in mesenchymal lung cancer

ABSTRACT:

SUBMITTER: Abdollahi A 

PROVIDER: S-EPMC12338787 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature